Cambridge Investment Research Advisors
DBEZ icon

Cambridge Investment Research Advisors’s Xtrackers MSCI Eurozone Hedged Equity ETF DBEZ Stock Holding History

Cambridge Investment Research Advisors’s Portfolio DBEZ Stock Details DBEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339K Hold
5,400
– – ﹤0.01% 3337
2026
Q1 		$297K Hold
5,400
– – ﹤0.01% 3304
2025
Q4 		$298K Buy
5,400
+1,350
+33% +$73.5K ﹤0.01% 3213
2025
Q3 		$216K Buy
+4,050
New +$210K ﹤0.01% 3416

Other funds holding DBEZ

AWM
Affinity Wealth Management Wilmington, Delaware $776M AUM 43.59% 1-Year Est. Return
SA
Sonoma Allocations Santa Rosa, California $322M AUM 23.6% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

Cambridge Investment Research Advisors's DBEZ Position: Q2 2026 in Review

Cambridge Investment Research Advisors held its Xtrackers MSCI Eurozone Hedged Equity ETF (DBEZ) position steady in Q2 2026 at 5,400 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #3337.

Cambridge Investment Research Advisors first reported a position in DBEZ in Q3 2025 and has held it in 4 quarters since. 5 funds tracked by Wall St. Rank hold DBEZ as of Q2 2026.

  • Cambridge Investment Research Advisors held 5,400 shares of Xtrackers MSCI Eurozone Hedged Equity ETF worth $339K as of Q2 2026.
  • Cambridge Investment Research Advisors left its Xtrackers MSCI Eurozone Hedged Equity ETF share count unchanged in Q2 2026.
  • Xtrackers MSCI Eurozone Hedged Equity ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3337 holding.
  • Cambridge Investment Research Advisors first reported a position in Xtrackers MSCI Eurozone Hedged Equity ETF in Q3 2025 and has held it in 4 quarters since.
  • 5 funds tracked by Wall St. Rank held Xtrackers MSCI Eurozone Hedged Equity ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.